BioSpace News Archive

Lead Product, ReminX™, a First of its Kind Digital Reminiscence Therapy Platform to Launch in Q2

Organization Calls on Federal, State and County Governments to Implement Programs that Better Support Victims of Non-Fatal Opioid Overdose

Study of new powered soft exo-suit for stroke rehabilitation is intended to provide clinical data for upcoming FDA submission

Magenta Therapeutics, a biotechnology company developing novel medicines to bring the curative power of bone marrow transplant to more patients, today announced that chief operating officer Bastiano Sanna, Ph.D., has resigned from the Company, effective March 30, to pursue an opportunity outside of Magenta. Dr. Sanna has agreed to assist Magenta in an advisory capacity through the second quarter of 2018.

Company’s Solution is a MicroRNA Biomarker Detecting Patient’s Risk for Relapse at Diagnosis

Vybion announces the issue by the USPTO of Patent No. 9932394 entitled, “Single Chain Intrabodies that Alter Huntingtin Mutant Degradation”. Issued claims cover composition of matter as well as both the Huntingtin and Tau protein targets with the potential for treatment of both Huntington’s and Alzheimer’s diseases.

Nonprofit Leverages One Network’s Real Time Value Network to Help Ensure Timely Availability of Essential Products for Low and Middle-income Countries

- Trial Participant Pack for patients offers information and first-person narratives to fill knowledge gaps and demystify clinical studies - Trial Resource Pack for trial teams shares best practices and tools for recruitment and retention - Suite made possible by pharmaceutical and biotech members of MJFF’s Parkinson’s Disease Education Consortium

The Illinois Employer Support of the Guard and Reserve (ESGR) Awards program has selected Astellas for its highest honor - the Pro Patria Award - as the state’s top large employer over the past year.

Proof-of-concept preclinical study supports feasibility of Alivio’s technology platform as a potential new treatment approach for inflammatory arthritis